Exelixis Inc. is an oncology-focused biotechnology company dedicated to the discovery, development, and commercialization of new medicines for difficult-to-treat cancers. Its lead product, CABOMETYX t... Exelixis Inc. is an oncology-focused biotechnology company dedicated to the discovery, development, and commercialization of new medicines for difficult-to-treat cancers. Its lead product, CABOMETYX tablets (cabozantinib), treats advanced renal cell carcinoma in patients following prior anti-angiogenic therapy and supports expansion into indications like neuroendocrine tumors. COMETRIQ capsules (cabozantinib) address progressive, metastatic medullary thyroid cancer. The company also markets COTELLIC (cobimetinib) and advances a pipeline including zanzalintinib, evaluated in trials such as STELLAR-303 for metastatic colorectal cancer in combination with immune checkpoint inhibitors. Exelixis leverages expertise in chemistry, biology, and strategic partnerships to develop small molecules, bispecific antibodies, antibody-drug conjugates, and other innovative anti-cancer therapies. These efforts target tyrosine kinases like MET, AXL, RET, and VEGF receptors, aiming to inhibit cancer growth and metastasis. Founded in 1994 and headquartered in Alameda, California, Exelixis plays a vital role in oncology by challenging treatment norms and broadening therapeutic options for patients worldwide.Show lessShow more

Disclosures ESG Data Financial Data

Income Statement Balance Sheet Group Entities

Data not available

Group Entities data not yet covered for Exelixis

We have not yet reviewed Exelixis's disclosures for Group Entities data.

If this data is relevant to your work, you can submit a data coverage request and our team will investigate the company's disclosures and capture the data if available.

Would you like us to review Exelixis's data?

Start your 30-day free trial to request a data review for Exelixis.

Start Free Trial

Legal Center Contact Us

Exelixis Inc

Group Entities data not yet covered for Exelixis

Account Restricted